Ingelvac® PRRS MLV2007 Boehringer Ingelheim Advancement in PRRS Research Award Recipients AnnouncedBoehringer Ingelheim Vetmedica, Inc., is committed to learning more about understanding and managing the PRRS virus... PRRS Risk Assessment ToolA web-based version of the PRRS Risk Assessment Tool for the Breeding Herd is in development and should be available online this summer... Finishers Benefit from PRRS ProtectionJust when many U.S. sow herds are reaching a state of PRRS stability, the virus is cropping up elsewhere along the production chain... PRRS Protection in Commingled Pig FlowsIf there is strength in numbers, a field study conducted by Boehringer Ingelheim Vetmedica, Inc. (BIVI), should leave little doubt as to the impact of Ingelvac PRRS ATP... Managing PRRS Virus in Commingled Pig FlowsCombining nursery pigs from different sources can present several challenges to managers of grow-finish farms... Respiratory Vaccines, Timing Impact PCV2Type 2 porcine circovirus (PCV2) is now associated with several diseases, including postweaning multisystemic wasting syndrome (PMWS), reproductive disorders, porcine... What about heterologous protection?Because PRRS shows such ability to mutate, the natural question arises: Can a mass-vaccination program protect animals if a differing strain is introduced?... Another tool in the PRRS-management toolboxThe United States Department of Agriculture has approved the use of Ingelvac PRRS MLV vaccine for whole-herd (boars excluded) vaccination in PRRS-positive... Testing your progressTo accomplish ideal control, vaccination, medication and management changes must be timed to their ideal point in the disease cycle. Effective testing... Health actions to maximize performanceWhen disease agents have entered the herd, intervention may become necessary. Once you've identified the agents, and evaluated the economic impact, a... PRRS in the breeding herd What to expectPRRS virus has evolved many unique features to survive. One of its is the slow recognition of the virus by the pig a pig's immune system does not initially... Keep what you have!Much attention is paid to breeding stock inventories when the quarterly USDA reports arrive. Will the herd expand and prices go down? Are gilt marketings... Ingelvac HP-1 breaks new groundBoehringer Ingelheim Vetmedica, Inc. is happy to announce the introduction of a new single dose vaccine for Haemophilus parasuis. Ingelvac HP-1 is the... PRRS Immunity Unconventional, adapt strategiesNew research into PRRS virus and the reaction of the immune system has helped shed light on how the immune response to PRRS is unique. Teams at the University... Growing Pigs A new look at PRRS stabilityResearchers in Canada chose herds that were PRRS stable, whether they were vaccinated or non-vaccinated. Stability was defined as 90% or more of the sows... Is there value in autogenous PRRS vaccination?An Iowa State study reported at the 1999 Allen D. Leman Swine Conference evaluated the potential benefits of using an autogenous killed PRRS vaccine alone... Long term, in-field evaluation of PRRS vaccinationNewly reported research from Germany tracked the effectiveness of using modified live PRRS vaccination in both a 6000-head finishing operation and a 1300-sow... The impact of PRRS virus exposure doseResearch reported late last year challenged groups of pregnant sows with a virulent PRRS strain (NADC-8) at doses of either 100, 10,000 or 1 million tissue... Worldwide resources link you to innovative health solutionsBoehringer Ingelheim Vetmedica, Inc., is a family-owned organization headquartered in St. Joseph, Mo. It ranks among the top ten animal health product... Use of quality management tools to control PRRSResearch reported at the 2000 annual meeting of the American Association of Swine Practitioners demonstrates that the Continuous-Improvement measurement... |